All lobbying filings

Bell & Lindsay, Inc.

Bell & Lindsay, Inc. filed a Q4 report for Metabolic Syndrome Insulin Infusion Holdings LLC on January 20, 2026, reporting $15,000 in lobbying income.

Lobbying for Metabolic Syndrome Insulin Infusion Holdings LLC · treatment of metabolic disorders, including diabetes.

As filed: BELL & LINDSAY, INC. for METABOLIC SYNDROME INSULIN INFUSION HOLDINGS LLC.

All filings by Bell & Lindsay, Inc. · Everything Metabolic Syndrome Insulin Infusion Holdings LLC has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$15,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Lobbyists on this filing 1

MARK F LINDSAY

Previously held: U.S House Staff

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Accounting

education around MSII's value proposition to treat metabolic health disorders.

Health Issues

education around MSII's value proposition to treat metabolic health disorders.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.